Neurobiological Impact of Stimulants, Depressants, and Hallucinogens

The podcast, hosted by Dr. Donnelly Snipes, delves into the neurobiological impact of stimulants and depressants, explaining how these psychoactive drugs alter neurotransmitter balance. It introduces fundamental concepts like tolerance and withdrawal, illustrating them with relatable analogies. The discussion emphasizes that all psychoactive substances cause shifts in brain chemistry, leading to the body's adaptive responses that define tolerance and the subsequent rebound effects characteristic of withdrawal. The episode also highlights how the method of administration significantly influences a drug's onset and intensity. A crucial distinction is made regarding individual variability in drug response, influenced by factors such as body size, fat percentage, overall health, existing medical conditions (e.g., cardiac, thyroid, ADHD), and inherent neurotransmitter levels. The podcast differentiates between stimulants, which excite the central nervous system by activating the HPA axis and enhancing excitatory neurotransmitters like norepinephrine and dopamine, and depressants, which slow down the system, primarily by facilitating GABA and inhibiting glutamate. It also explains the four main pharmacological mechanisms by which drugs increase neurotransmitter levels: increased release, prolonged synaptic presence (by preventing reuptake or reducing degradation), or reverse action of reuptake transporters. Practical insights include recognizing the potential for both therapeutic and recreational use of stimulants (e.g., for asthma, ADHD, narcolepsy) and depressants (e.g., pain relief, anti-anxiety, sleep aids). The host advises caution regarding concurrent drug use, noting the exponential additive effects of mixing depressants, which can lead to severe respiratory depression. For individuals undergoing detox, particularly from opioids, the importance of supervised withdrawal and gradual tapering is stressed to manage unpleasant symptoms, prevent dehydration, and mitigate the high risk of overdose due to rapidly decreasing tolerance post-cessation. Awareness of environmental factors like VOCs in paints is also mentioned as a potential influence on mood. The broader implications extend to public health, particularly concerning the opioid crisis and the dangers of illicitly produced substances like methamphetamine and fentanyl, which have varying potencies and longer half-lives leading to more severe withdrawals. The discussion touches upon the long-term physiological and psychological consequences of chronic substance use, including organ damage, mental health issues (depression, paranoia, anxiety), and the body's reduced production of natural painkillers. The specific risks for vulnerable populations, such as the elderly with benzodiazepine use due to impaired liver clearance, underscore the need for careful medical monitoring and personalized treatment approaches in managing substance use and mental health.

all psychoactive drugs cause alterations in your neurotransmitter balance

basically you can think of substance use whatever action it produces withdrawal is going to be the opposite action

the method of administration greatly affects the intensity and duration of onset for just about any drugs that you take

drugs affect everybody differently based on their size... their body fat percentage... people's health... their biological neurotransmitter levels

stimulants are substances that excite the central nervous system by activating that hpa axis or your threat response system

depressants exert the opposite effect of stimulants because they slow everything down

when the body starts getting flooded with exogenous opioids... it quits making its endogenous it's natural painkillers

tolerance decreases rapidly so after somebody's been off opioids... if they relapse and they start using at the same dose that they were using when they stopped they are really likely to be using too much and they are at high risk for overdose